On August 20, 2019, a pre-NDA meeting for the inhalated nitric oxide (trade name: INOMAX) was held at the Drug Evaluation Center of the NMPA. Participants at the conference included Minister Ma Yunan, Vice Minister Wang Yamin, Yu Hong (senior reviewer), Liu Fuli (chief reviewer), Shi Jingfen, other reviewers and manufacturer representatives, Callie Gautreaux and Stacy Woeppel, as well as represnetatives from the registered agents of Zhaoke Pharmaceutical (Hefei) Co., Ltd., Dr. Dai Xiangrong, Dr. Huang Sijia, Shi Min, Li Dongmei, Wang Xuyu.
Thai 
English